Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Research & Development (2010 - 2026)

Updated

Corcept Therapeutics' Research & Development came in at $53.89 million for Q2 2026, down 10.9% from $60.47 million a year earlier and down 18.7% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Corcept Therapeutics reported Research & Development of $253.86 million, up 1.2% year-over-year; for FY2025, it was $254.91 million, up 3.2% from FY2024.

  • Research & Development has increased in each of the last four years, with a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
  • Going back by year, Research & Development was $246.89 million in FY2024 (+33.9%), $184.35 million in FY2023 (+40.7%), $130.99 million in FY2022 (+15.0%) and $113.86 million in FY2021 (-0.8%).
  • The Q2 2026 figure represents the lowest quarterly Research & Development since Q3 2023.
  • Year-over-year, Research & Development increased in six of the last eight quarters, with growth averaging 9.0%.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2023 (growth of 48.8%), and the weakest in Q3 2021 (a decline of 17.1%).
  • Business Quant data shows CORT's Research & Development at $66.27 million (Q1 2026), $64.86 million (Q4 2025) and $68.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 53.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.89 Mn
Mar 31, 2026 66.27 Mn
Dec 31, 2025 64.86 Mn
Sep 30, 2025 68.85 Mn
Jun 30, 2025 60.47 Mn
Mar 31, 2025 60.74 Mn
Dec 31, 2024 70.30 Mn
Sep 30, 2024 59.34 Mn
Jun 30, 2024 58.75 Mn
Mar 31, 2024 58.51 Mn
Dec 31, 2023 54.71 Mn
Sep 30, 2023 45.52 Mn
Jun 30, 2023 43.28 Mn
Mar 31, 2023 40.85 Mn
Dec 31, 2022 36.75 Mn
Sep 30, 2022 33.29 Mn
Jun 30, 2022 32.83 Mn
Mar 31, 2022 28.12 Mn
Dec 31, 2021 28.52 Mn
Sep 30, 2021 28.09 Mn
API Access

Corcept Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CORT&period=max&api_key=YOUR_API_KEY